Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

NIH awards $3.8 million to predict dementia in patients with Parkinson's disease

The National Institute of Neurological Disorders and Stroke at the National Institutes of Health has awarded a grant expected to total $3.8 million to Virendra Mishra, Ph.D., associate staff at Cleveland Clinic Lou Ruvo Center for Brain Health, to identify biomarkers - or disease indicators - to predict dementia in patients with Parkinson's disease.

6 Oct 2020

Stud shows possibility for regenerating neurons in the eye and brain

The death of neurons, whether in the brain or the eye, can result in a number of human neurodegenerative disorders, from blindness to Parkinson's disease. Current treatments for these disorders can only slow the progression of the illness, because once a neuron dies, it cannot be replaced.

5 Oct 2020

Parkinson's disease is an independent risk factor for dying from COVID-19, study suggests

A new study of approximately 80,000 patients shows that people with Parkinson's disease (PD) have a 30% higher risk of dying from COVID-19 than people without the neurodegenerative condition.

1 Oct 2020

Researchers develop unique diagnostic tool to detect dystonia from MRI scans

Researchers at Mass Eye and Ear have developed a unique diagnostic tool that can detect dystonia from MRI scans, the first technology of its kind to provide an objective diagnosis of the disorder.

29 Sep 2020

Spinal cord stimulation improves pain and motor symptoms in Parkinson’s disease

A team of researchers in the United States and Japan reports that spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson's disease, both as a singular therapy and as a "salvage therapy" after deep brain stimulation (DBS) therapies were ineffective.

28 Sep 2020

Study demonstrates a proof-of-concept stem cell treatment in Parkinson's disease mouse model

The mature brain is infamously bad at repairing itself following damage like that caused by trauma or strokes, or from degenerative diseases like Parkinson's. Stem cells, which are endlessly adaptable, have offered the promise of better neural repair.

25 Sep 2020

FDA issues updated recommendations concerning dental amalgam

Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.

25 Sep 2020

Experts review common and vexing issues affecting people with Parkinson's disease

Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society.

24 Sep 2020

Chaperone-mediated autophagy could be a new therapeutic target for spinocerebellar ataxia

A research team from Kumamoto University, Japan has developed an animal model that reproduces motor dysfunction and cerebellar neurodegeneration similar to that in spinocerebellar ataxia (SCA) by inhibiting chaperone-mediated autophagy (CMA) in cerebellar neurons.

23 Sep 2020

'Silent' wave of neurological consequences may be on its way due to COVID-19

Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health.

23 Sep 2020

Parkinson's disease diagnosed after SARS-CoV-2

As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 describes a case of new-onset Parkinson's disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Sep 2020

Existence of brain-first and body-first Parkinson’s disease subtypes

Although the name may suggest otherwise, Parkinson's disease is not one but two diseases, starting either in the brain or in the intestines.

22 Sep 2020

New $6.2 million study seeks to define molecular linkages between aging and Parkinson's

A collaborative team between the University of Minnesota Medical School and Van Andel Institute will soon begin a $6.2 million study that seeks to define the molecular linkages between aging and Parkinson's disease -- an approach for new treatment targets not yet explored by many researchers.

21 Sep 2020

Innovative approach for identifying new molecules to help track progression of Parkinson's

For many of the 200,000 patients diagnosed with Parkinson's disease in the United States every year, the diagnosis often occurs only after the appearance of severe symptoms such as tremors or speech difficulties.

21 Sep 2020

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye.

21 Sep 2020

Astrocytes are essential for blood-brain barrier health, shows study

Hard skulls help protect our brains from physical injuries.In addition to a tough outer shell, brains have internal defenses, including a powerful shield called the blood-brain barrier that defends brain cells from substances in the bloodstream that are toxic and dangerous to nerve cells. If the blood-brain barrier is breached, then health problems arise.

21 Sep 2020

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

NIH awards $3.8 million to predict dementia in patients with Parkinson's disease

Stud shows possibility for regenerating neurons in the eye and brain

Parkinson's disease is an independent risk factor for dying from COVID-19, study suggests

Researchers develop unique diagnostic tool to detect dystonia from MRI scans

Spinal cord stimulation improves pain and motor symptoms in Parkinson’s disease

Study demonstrates a proof-of-concept stem cell treatment in Parkinson's disease mouse model

FDA issues updated recommendations concerning dental amalgam

Experts review common and vexing issues affecting people with Parkinson's disease

Chaperone-mediated autophagy could be a new therapeutic target for spinocerebellar ataxia

'Silent' wave of neurological consequences may be on its way due to COVID-19

Parkinson's disease diagnosed after SARS-CoV-2

Existence of brain-first and body-first Parkinson’s disease subtypes

New $6.2 million study seeks to define molecular linkages between aging and Parkinson's

Innovative approach for identifying new molecules to help track progression of Parkinson's

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

Astrocytes are essential for blood-brain barrier health, shows study

Researchers describe details of protein linked to genetically inherited Parkinson's disease

Smart drug delivery system may help treat spinal cord injuries, neurological disorders

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

Physical exercise protocol can mitigate the severity of Parkinson's disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in